網頁2024年9月20日 · SEATTLE, Sept. 20, 2024 /PRNewswire/ -- Magnolia Medical Technologies, Inc. announced today that it has been awarded an Innovative Technology … 網頁2024年11月28日 · According to the study, a single false positive blood culture event results in an additional $4,739 in hospital costs on average. Depending on a facility's baseline contamination rate (ranging from 2-8 percent), hospitals can expect a cost savings between $83 and $367 per blood culture following adoption of the Steripath ISDD, researchers said.

Magnolia Medical Technologies, Inc. - 617922 - 09/17/2024

網頁2024年3月28日 · Steripath Gen2 is the simple, all-in-one solution clinically proven to reduce false-positive blood culture results. Actively diverts and sequesters the initial 1.5-2.0mL of blood, the volume known to contain contaminants.³ Blood cultures are then collected through a second flow path, creating a closed vein-to-bottle collection system. 網頁2024年1月6日 · AccessGUDID - SteriPath Gen2, 21G, 10ml (00858366007221)- Steripath Blood Collection System, Sterile Pack, 21G, 10ml Syringe Skip to Main Content National … dun and bradstreet firmographic data

Magnolia Medical Launches New Steripath Gen2 with …

網頁2024年11月28日 · rate (ranging from 2-8 percent), hospitals can expect a cost savings between $83 and $367 per blood culture following adoption of the Steripath ISDD, … 網頁compromise the sensitivity of blood culture tests 29 and had the potential to be cost-saving due to the small device cost ... costs from $4,500 -13,000 per contaminant. 2, 4 , 6,7 … 網頁2024年3月20日 · 510 (k) Number. K200661. Device Name. Steripath Micro Blood Collection System. Applicant. Magnolia Medical Technologies Inc. 200 West Mercer Street, Suite … dun and bradstreet greensboro nc